Checkmate Pharmaceuticals, Inc.

CMPIDelisted May 31, 2022

Industry: Biological Products, (No Diagnostic Substances)
SEC CIK: 0001651431

SEC filings (opens in a new tab)

Checkmate Pharmaceuticals, Inc. was delisted on May 31, 2022; its insiders filed their last Form 4 on May 31, 2022; 26 institutions reported holding it in 13F filings for Q1 2022, worth $54.8M in total; no superinvestor held it.

Key figures

Market cap: –; Not available
Insider buys: 0; Open market, last 90 days
Insider sells: 0; Open market, last 90 days
13F holders: 26; Q1 2022, +1 vs. previous quarter
13F value: $54.8M; Reported value at the end of Q1 2022
Superinvestors holding: 0; At the end of Q1 2022

Financials

See financial statements

From SEC filings, in USD.

Revenue, FY2021: –; No comparable prior period
Net income, FY2021: -$61.4M; No comparable prior period
Free cash flow, FY2021: -$54.6M; No comparable prior period
Revenue, Q1 FY2022: –; No comparable prior period

Superinvestors holding CMPI, Q1 2022

Go to the superinvestors tab

No superinvestor reported holding CMPI at the end of Q1 2022.

Latest insider trades

See all insider trades

Open-market purchases and sales by Checkmate Pharmaceuticals, Inc. insiders from Form 4, newest first.

Insider trades
Filed (ET)	Trade date	Filing delay	Insider	Transaction	Shares	Avg price	Value	Holding change	Flags
May 17, 2022 (view filing)5:12 PM ET	May 13-16	4 days	Goodman Corey S and 4 others10% Owner	SSale	−131.7K	$10.45	−$1.38M	−5.8%2.16M after	2 lots
May 12, 2022 (view filing)8:47 PM ET	May 10-12	2 days	Goodman Corey S and 4 others10% Owner	SSale	−160.9K	$10.39	−$1.67M	−6.6%2.29M after	3 lots
May 9, 2022 (view filing)6:58 PM ET	May 5-9	4 days	Goodman Corey S and 4 others10% Owner	SSale	−86.7K	$10.37	−$898.9K	−3.4%2.45M after	3 lots
May 4, 2022 (view filing)7:30 PM ET	May 2-4	2 days	Goodman Corey S and 4 others10% Owner	SSale	−270.7K	$10.38	−$2.81M	−9.6%2.54M after	3 lots
Apr 29, 2022 (view filing)5:50 PM ET	Apr 27-29	2 days	Goodman Corey S and 4 others10% Owner	SSale	−190.0K	$10.38	−$1.97M	−6.3%2.81M after	3 lots
Apr 26, 2022 (view filing)6:40 PM ET	Apr 22-26	4 days	Goodman Corey S and 4 others10% Owner	SSale	−129.8K	$10.39	−$1.35M	−4.2%3.00M after	3 lots
Apr 21, 2022 (view filing)8:54 PM ET	Apr 19-21	2 days	Goodman Corey S and 4 others10% Owner	SSale	−547.7K	$10.41	−$5.70M	−14.9%3.13M after	3 lots
Feb 25, 2022 (view filing)	Feb 23-25	2 days	Novo Holdings A/S10% Owner	SSale	−8.11K	$2.84	−$23.0K	−0.4%2.16M after	3 lots

Top 10 13F holders, Q1 2022

See all 26 holders

The largest institutional positions in Checkmate Pharmaceuticals, Inc. at the end of Q1 2022; share changes are against Q4 2021.

Institutions holding CMPI in Q1 2022
Institution	Shares	Value	% of portfolio	Change in shares	Action
venBio Partners LLC	3,673,374	$11.7M	2.60%	00.0%	Unchanged
Sofinnova Investments, Inc.	3,606,707	$11.5M	0.97%	00.0%	Unchanged
Novo Holdings A/S	2,161,990	$6.90M	0.36%	−8,110−0.4%	Reduced
Medicxi Ventures Management (Jersey) Ltd	1,501,716	$4.79M	1.30%	00.0%	Unchanged
Omega Fund Management, LLC	1,335,050	$4.26M	0.87%	00.0%	Unchanged
Decheng Capital Management III (Cayman), LLC	1,333,254	$4.25M	1.30%	+1,333,254	New
Clough Capital Partners L P	1,137,764	$3.63M	0.28%	−168,862−12.9%	Reduced
FMR LLC	966,226	$3.08M	0.00%	−1,000−0.1%	Reduced
Vanguard Group Inc	556,423	$1.77M	0.00%	−23,438−4.0%	Reduced
Sectoral Asset Management Inc	541,765	$1.73M	0.31%	−10.0%	Reduced